Acorda Therapeutics (NASDAQ:ACOR) reported Q1 2018 earnings this Morning, coming in at $0.14 per share, missing Wall Street’s estimates of $0.68 per Share. Revenue for the quarter came in at $106.17 million missing the streets estimates of $130.94 million Recent Insider Trading for Acorda Therapeutics (NASDAQ:ACOR)
- On 1/19/2018 David Lawrence, Insider, sold 31,000 with an average share price of $27.58 per share and the total transaction amounting to $854,980.00.
- On 12/1/2017 Burkhard Blank, Insider, sold 11,050 with an average share price of $20.53 per share and the total transaction amounting to $226,856.50.
- On 10/9/2017 David Lawrence, Insider, sold 250 with an average share price of $25.40 per share and the total transaction amounting to $6,350.00.
- On 8/29/2017 Scopia Capital Management Lp, Major Shareholder, bought 766,201 with an average share price of $19.23 per share and the total transaction amounting to $14,734,045.23.
- On 8/1/2017 Barry E Greene, Director, sold 10,000 with an average share price of $21.57 per share and the total transaction amounting to $215,700.00.
- On 7/31/2017 Lorin Randall, Director, sold 10,000 with an average share price of $21.66 per share and the total transaction amounting to $216,600.00.
Dividend History for Acorda Therapeutics (NASDAQ:ACOR)
Recent Trading for Acorda Therapeutics (NASDAQ:ACOR) Shares of Acorda Therapeutics closed the previous trading session at 23.45 up +0.35 1.52% with shares trading hands.